Head and Neck Cancer Salvage Surgery in the Era of Immunotherapy and Beyond
Advances in immunotherapy and the development of future clinical trials incorporating immunotherapy in the HNSCC salvage setting have the potential to enhance patient selection and optimize surgical outcomes.
Authors
- Robert Paul Takes (ORCID: https://orcid.org/0000-0003-4784-0499)
- Jan B. Vermorken (ORCID: https://orcid.org/0000-0001-8515-7848)
- Alfio Ferlito (ORCID: https://orcid.org/0000-0002-8247-8002)
- Arlene A. Forastiere (ORCID: https://orcid.org/0000-0003-2238-3682)
- Nabil F. Saba (ORCID: https://orcid.org/0000-0003-4972-1477)
- Carol R. Bradford (ORCID: https://orcid.org/0000-0002-2768-4532)
- Jonathan J. Beitler (ORCID: https://orcid.org/0000-0002-1519-2071)
- Karthik Rao (ORCID: https://orcid.org/0000-0002-1420-7366)
- Nicole C. Schmitt (ORCID: https://orcid.org/0000-0002-0571-3531)
- Anthea L. Hammond
- Yong Teng (ORCID: https://orcid.org/0000-0002-1856-7289)
- Nader Zalaquett (ORCID: https://orcid.org/0009-0008-7206-152X)
- Saad Rashid
- Remco de Bree
Institutions
- Johns Hopkins University (US)
- Radboud University Nijmegen (NL)
- University of Antwerp (BE)
- Emory University (US)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Piedmont Cancer Institute (US)
- Antwerp University Hospital (BE)
- St. Louis VA Medical Center (US)
- HCG Cancer Hospital (IN)
- Cancer Hospital and Research Institute (IN)
- Mercy Health (US)
- The Ohio State University (US)
- American University of Beirut (LB)
Publication Details
- Journal
- JAMA Otolaryngology–Head & Neck Surgery
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1001/jamaoto.2025.3204
- Citations
- 2
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.70